Scientists in US and Australia team up for ASF vaccine

게시됨 2023년 11월 14일

Tridge 요약

Australian and US scientists are collaborating to develop a safe and effective vaccine against African Swine Fever (ASF). The vaccine candidate, which is a novel DNA vaccine, will be evaluated at Australia's national science agency's secure laboratories. The goal is to create a vaccine that can be used safely in all stages of swine production and prevent disease transmission within the herd and environment.
면책 조항: 위의 요약은 정보 제공 목적으로 Tridge 자체 학습 AI 모델에 의해 생성되었습니다.

원본 콘텐츠

Scientists from Australia and the USA are teaming up to develop a safe and effective vaccine against African Swine Fever (ASF). That news was shared at the website of Australia’s national science agency (CSIRO). The agency is working with US biotech firm MBF Therapeutics to evaluate their novel DNA vaccine candidate for ASF. While Australia has never had an outbreak of ASF, it has recently spread through Asia, with also outbreaks in Indonesia and East Timor (since 2019) and Papua New Guinea (2020). The scientists will evaluate the vaccine in the secure laboratories at CSIRO’s Australian Centre for Disease Preparedness (ACDP), a high biocontainment facility in Geelong (Victoria state) designed to safely enable research into the world’s most dangerous diseases. Dr David Williams, an ASF expert at ACDP, said, “While first-generation vaccines have recently been approved for use in some parts of Asia, these are weakened live virus vaccines, which have potential to revert back to a ...

더 깊이 있는 인사이트가 필요하신가요?

귀사의 비즈니스에 맞춤화된 상세한 시장 분석 정보를 받아보세요.
'쿠키 허용'을 클릭하면 통계 및 개인 선호도 산출을 위한 쿠키 제공에 동의하게 됩니다. 개인정보 보호정책에서 쿠키에 대한 자세한 내용을 확인할 수 있습니다.